HHS Secretary Xavier Becerra sent a letter to providers and insurers June 9 reminding them that billing patients for COVID-19 vaccines is prohibited.
The letter comes after reports have highlighted Americans’ concerns about facing unexpected costs associated with the vaccine and testing. Mr. Becerra specifically cited a recent The New York Times article that found fear of surprise bills could be contributing to vaccine hesitancy.
“We recognize that there are costs associated with administering the vaccines — from staff trainings to vaccine storage. For these expenses, providers may not bill patients but can seek reimbursement through Medicare, Medicaid, private insurance, or other applicable coverage,” Mr. Becerra said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
